AstraZeneca has explored an acquisition of Bristol Myers Squibb, according to people familiar with the matter. It’s unclear if discussions are ongoing or whether they will result in a transaction, the people cautioned. A representative for AstraZeneca declined to comment and Bristol Myers Squibb couldn’t immediately be reached for comment on the talks. Bloomberg's Manuel Baigorri reports. (Source:
Finance Bloomberg Aug 3, 2026